Biotechnology Health Data Life Sciences Pharmaceuticals 
HIT Consultant
JANUARY 14, 2022
. – Existing Verana Health investors GV (formerly Google Ventures), Casdin Capital , and Brook Byers also joined the round, as well as notable new investors, including the Merck Global Health Innovation Fund , THVC , and Breyer Capital. Empowering Physicians & Life Science Companies. Expansion Plans.
HIT Consultant
OCTOBER 20, 2023
What You Should Know: Gero , a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. Earlier this year, Gero announced a research partnership with Pfizer and is in talks with other pharmaceutical companies interested in addressing age-related diseases as a growing market.
Expert insights. Personalized for you.
98 
Let's personalize your content